Patent · US Expired

Uses for non-autologous mesenchymal stem cells

US6355239B1 · kind B1 · utility

282Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 1999
Grant dateMar 12, 2002
Priority date
Expiry dateMar 12, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2035/124
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and devices using non-autologous mesenchymal stem cells comprising treating a recipient in need thereof with an effective amount of non-autologous mesenchymal stem cells, including methods and preparations for treating and regenerating connective tissue and enhancing bone marrow engraftment in an individual; and for using genetically engineered allogeneic human mesenchymal stem cells that carry within them genes of interest particularly for the expression of physiologically or pharmacologically active proteins in gene therapy for correction of genetic disorders or “rebuilding” proteins important in tissue repair.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.